Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NSF Grants Awarded to University of Minnesota; Northeastern University


Recent NSF Awards in Proteomics and Protein Research

Title: Predicting and Mining Phenome-Genome Association across Species
Principal Investigator: Rui Kuang
Sponsor: University of Minnesota-Twin Cities
Start/End Date: Aug. 1, 2012 – July 31, 2017
Amount Awarded to Date: $83,847

Funds the development of algorithms to predict and interpret associations between genotype and phenotype across a variety of species. Once developed, the methods will be applied to the study of growth phenotypes in Arabidopsis thaliana and in the analysis of phenotypes in several tumor types.

Title: Precise Characterization of Conformational Ensembles
Principal Investigators: Lee Makowski; Dana Brooks; Deniz Erdogmu
Sponsor: Northeastern University
Start/End Date: July 1, 2012 – June 30, 2015
Amount Awarded to Date: $657,070

Funds an effort to characterize the set of all shapes particular proteins can take – their full conformational ensemble – by collecting wide-angle x-ray solution scattering data from the target proteins under a variety of different conditions. This will enable the creation of a map of protein conformational changes that can be used to further functional studies.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.